Potentials of plant-based substance to inhabit and probable cure for the COVID-19.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Jahan I;Jahan I; Onay A; Onay A
  • Source:
    Turkish journal of biology = Turk biyoloji dergisi [Turk J Biol] 2020 Jun 21; Vol. 44 (3), pp. 228-241. Date of Electronic Publication: 2020 Jun 21 (Print Publication: 2020).
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID: 9434434 Publication Model: eCollection Cited Medium: Internet ISSN: 1303-6092 (Electronic) Linking ISSN: 13000152 NLM ISO Abbreviation: Turk J Biol Subsets: PubMed not MEDLINE
    • Publication Information:
      Original Publication: Ankara : Scientific and Technical Research Council of Turkey, 1994-
    • Abstract:
      COVID-19 has been the most devastating pandemic in human history. Despite the highest scientific efforts and investments, a reliable and certified medication has yet to be developed regarding to immune or cure this virus. However, while synthetic medications are gaining the focus of attentions, it appears from a significant number of recent studies that plant-based substances could also be potential candidates for developing effective and secure remedies against this novel disease. Citing such recent works, this review primarily demonstrates the antiviral potentials of medicinal plants for inhibiting human coronaviruses. It also shows the importance of antiviral plants substances, particularly in the development of a broad spectrum medication for coronaviruses including SARS-CoV-2 responsible for COVID-19.
      Competing Interests: CONFLICT OF INTEREST: none declared
      (Copyright © 2019 The Author(s).)
    • References:
      Int J Antimicrob Agents. 2020 May;55(5):105938. (PMID: 32171740)
      Fitoterapia. 2005 Jun;76(3-4):374-8. (PMID: 15890472)
      Bioorg Med Chem. 2010 Nov 15;18(22):7940-7. (PMID: 20934345)
      Nat Microbiol. 2020 Apr;5(4):562-569. (PMID: 32094589)
      Bioorg Med Chem. 2013 Aug 1;21(15):4706-13. (PMID: 23746631)
      Scientifica (Cairo). 2020 Dec 23;2020:6307457. (PMID: 33425427)
      Bioorg Med Chem. 2013 Jun 1;21(11):3051-7. (PMID: 23623680)
      Biomolecules. 2019 Nov 04;9(11):. (PMID: 31690059)
      J Ethnopharmacol. 1998 Mar;60(2):163-72. (PMID: 9582007)
      Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507)
      Adv Virus Res. 1997;48:1-100. (PMID: 9233431)
      Trends Cell Biol. 2017 Nov;27(11):800-809. (PMID: 28642032)
      Int J Biol Sci. 2020 Mar 15;16(10):1708-1717. (PMID: 32226288)
      J Immunol Res. 2019 Apr 7;2019:6491738. (PMID: 31089478)
      J Virol. 2014 Jan;88(2):1293-307. (PMID: 24227843)
      Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
      Curr Drug Metab. 2018;19(3):236-263. (PMID: 29380697)
      Drug Deliv Transl Res. 2020 Apr;10(2):354-367. (PMID: 31788762)
      Chem Asian J. 2019 Nov 18;14(22):3962-3968. (PMID: 31389664)
      Antiviral Res. 2013 Dec;100(3):605-14. (PMID: 24121034)
      Antiviral Res. 2010 Nov;88(2):160-8. (PMID: 20727913)
      J Ethnopharmacol. 2008 Oct 30;120(1):108-11. (PMID: 18762235)
      PLoS One. 2016 Jan 05;11(1):e0146197. (PMID: 26730961)
      Mil Med Res. 2020 Mar 13;7(1):11. (PMID: 32169119)
      Nat Prod Res. 2008 Jan 10;22(1):53-65. (PMID: 17999339)
      Exp Ther Med. 2017 Jul;14(1):626-634. (PMID: 28672977)
      Antiviral Res. 2013 Jan;97(1):1-9. (PMID: 23153834)
      J Tradit Complement Med. 2011 Oct;1(1):41-50. (PMID: 24716104)
      Nat Rev Drug Discov. 2016 May;15(5):327-47. (PMID: 26868298)
      Int J Antimicrob Agents. 2020 Mar;55(3):105924. (PMID: 32081636)
      J Enzyme Inhib Med Chem. 2017 Dec;32(1):504-515. (PMID: 28112000)
      J Med Chem. 2007 Aug 23;50(17):4087-95. (PMID: 17663539)
      Nature. 2013 Nov 28;503(7477):535-8. (PMID: 24172901)
      Viruses. 2010 Aug;2(8):1804-1820. (PMID: 21994708)
      Trends Immunol. 2020 May;41(5):355-359. (PMID: 32249063)
      J Med Virol. 2020 Jun;92(6):540-545. (PMID: 32108352)
      J Virol. 2004 Oct;78(20):11334-9. (PMID: 15452254)
      Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7. (PMID: 15226499)
      Respirology. 2018 Feb;23(2):130-137. (PMID: 29052924)
      Antiviral Res. 2005 Jul;67(1):18-23. (PMID: 15885816)
      World J Gastroenterol. 2006 Sep 21;12(35):5721-5. (PMID: 17007029)
      J Altern Complement Med. 2006 Jul-Aug;12(6):505-6. (PMID: 16884338)
      J Virol. 2007 Feb;81(4):1574-85. (PMID: 17121802)
      J Virol. 2019 May 29;93(12):. (PMID: 30918074)
      Clin Exp Pharmacol Physiol. 2006 Jul;33(7):612-6. (PMID: 16789928)
      J Pharm Anal. 2020 Aug;10(4):313-319. (PMID: 32296570)
      Evid Based Complement Alternat Med. 2005 Jun;2(2):209-215. (PMID: 15937562)
      J Enzyme Inhib Med Chem. 2014 Feb;29(1):59-63. (PMID: 23323951)
      Cannabis Cannabinoid Res. 2020 Jun 05;5(2):118-120. (PMID: 32656343)
      Ethiop Med J. 2005 Jan;43(1):15-20. (PMID: 16370525)
      Am J Chin Med. 2006;34(1):13-21. (PMID: 16437735)
      Antiviral Res. 2009 Apr;82(1):73-81. (PMID: 19428598)
      Annu Rev Virol. 2020 Sep 29;7(1):83-101. (PMID: 32196426)
      Biochem Biophys Res Commun. 2019 Oct 22;518(4):732-738. (PMID: 31472967)
      J Struct Biol. 2011 Apr;174(1):11-22. (PMID: 21130884)
      Viruses. 2019 Mar 02;11(3):. (PMID: 30832341)
      J Ethnopharmacol. 2012 Jun 14;141(3):854-9. (PMID: 22465592)
      Biomed Res. 2015;36(3):219-24. (PMID: 26106051)
      Microbiologica. 1988 Jan;11(1):55-61. (PMID: 2832710)
      J Gen Microbiol. 1952 Feb;6(1-2):74-84. (PMID: 14927853)
      Phytomedicine. 2011 Mar 15;18(5):384-6. (PMID: 21036571)
      Bioorg Med Chem Lett. 2012 Jun 15;22(12):4049-54. (PMID: 22578462)
      Int J Nanomedicine. 2012;7:2173-9. (PMID: 22619553)
      Lancet. 2003 Jun 14;361(9374):2045-6. (PMID: 12814717)
      Antiviral Res. 2007 May;74(2):92-101. (PMID: 16730806)
      J Biol Chem. 2019 Sep 27;294(39):14406-14421. (PMID: 31399512)
      Phytomedicine. 2008 Sep;15(9):734-40. (PMID: 18693101)
      Emerg Microbes Infect. 2020 Dec;9(1):386-389. (PMID: 32065057)
      Methods Mol Biol. 2015;1282:1-23. (PMID: 25720466)
      Pharm Biol. 2012 Apr;50(4):401-6. (PMID: 22136493)
      Antiviral Res. 2018 Feb;150:123-129. (PMID: 29258862)
      J Med Microbiol. 2012 Jul;61(Pt 7):889-894. (PMID: 22322337)
      Mol Biol Rep. 2014 Mar;41(3):1703-11. (PMID: 24413991)
      Hong Kong Med J. 2011 Feb;17 Suppl 2:41-3. (PMID: 21368336)
      Phytother Res. 2018 May;32(5):811-822. (PMID: 29356205)
      J Ethnopharmacol. 1995 Dec 1;49(2):101-10. (PMID: 8847882)
      J Ethnopharmacol. 2008 Jun 19;118(1):79-85. (PMID: 18479853)
      BMC Infect Dis. 2017 Feb 13;17(1):144. (PMID: 28193191)
      Toxicol Appl Pharmacol. 2018 Oct 1;356:90-97. (PMID: 30053394)
      Antiviral Res. 2005 Oct;68(1):36-42. (PMID: 16115693)
      Phytother Res. 2004 Jul;18(7):592-4. (PMID: 15305324)
    • Contributed Indexing:
      Keywords: COVID 19; HCoV-229E; MERS-CoV; SARS-CoV; antiviral plants; coronaviruses; emodin; lycorine
    • Publication Date:
      Date Created: 20200630 Latest Revision: 20231111
    • Publication Date:
      20240105
    • Accession Number:
      PMC7314514
    • Accession Number:
      10.3906/biy-2005-114
    • Accession Number:
      32595359